Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria

Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria

The objective of this paper was to determine the effect of tamsulosin use on plasma insulin status in benign prostatic hyperplasia (BPH) patients in Sokoto, Nigeria. Standard methods and procedures were used. At 2nd and 3rd months of tamsulosin use, there was a significant increase (P<0.05) in p...

Descrizione completa

Dettagli Bibliografici
Autori principali:	M Dikko, S.O. Bello, A. Chika, I.A. Mungadi, Y. Sarkingobir, A.I. Umar
Natura:	Articolo
Lingua:	English
Pubblicazione:	Joint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP) 2020-05-01
Serie:	Journal of Applied Sciences and Environmental Management
Soggetti:	Tamsulosin, hyperinsulinemia, benign prostatic hyperplasia patients, insulin resistance
Accesso online:	https://www.ajol.info/index.php/jasem/article/view/196068

Documenti analoghi

Combination therapy with Tamsulosin plus Dutasteride Versus Tamsulosin in Benign Prostatic Hyperplasia: a Systematic review & Meta-analysis
di: Behnam Amani, et al.
Pubblicazione: (2023-02-01)

Comparing monotherapy with tadalafil or tamsulosin in men with benign prostatic hyperplasia: A case–control study
di: Hayder Adnan Fawzi, et al.
Pubblicazione: (2024-07-01)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
di: N. A. Avxentyev, et al.
Pubblicazione: (2016-09-01)

Early versus late trail of catheter removal in patients with urinary retention secondary to benign prostatic hyperplasia under tamsulosin treatment
di: Salem Hassan Salem Mohamed, et al.
Pubblicazione: (2018-01-01)

Review of Adverse Drug Reactions of Medicines used for the Treatment of Benign Prostatic Hyperplasia Reported to Halmed
di: Iva Kuliš, et al.
Pubblicazione: (2023-01-01)

Body Weight Determination and Histological Examination of Livers in Normal Rats Administered with Tamsulosin
di: M. Dikko, et al.
Pubblicazione: (2020-09-01)

Tamsulosin in the treatment of urological disorders - a literature review
di: Błażej Kaczmarek, et al.
Pubblicazione: (2025-03-01)

Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management
di: Rajeev Thekumpadam Puthenveetil, et al.
Pubblicazione: (2015-10-01)

Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study
di: Jun Ho Lee, et al.
Pubblicazione: (2023-12-01)

Finasteride and Tamsulosin Combination in Benign Prostatic Enlargement in a Tertiary Hospital
di: Binod Bade Shrestha, et al.
Pubblicazione: (2015-03-01)

Clinical portrait of an "ordinary" patient with benign prostatic hyperplasia and the efficacy of treating lower urinary tract symptoms
di: V. L. Medvedev, et al.
Pubblicazione: (2023-04-01)

Tamsulosin-induced priapism: A case report
di: Julie Martino, et al.
Pubblicazione: (2024-12-01)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
di: Sh. P. Abdullaev, et al.
Pubblicazione: (2024-05-01)

THE EFFECT OF TAMSULOSIN 0.4 MG ADMINISTRATION TOWARDS ALTERATION OF PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN BENIGN PROSTATIC HYPERPLASIA (BPH) PATIENTS IN PADANG CITY
di: Fadly Asril, et al.
Pubblicazione: (2024-05-01)

DOES HYPOGONADISM ON RESULTS TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA?
di: A. V. Sigaev, et al.
Pubblicazione: (2013-06-01)

Effect of Tamsulosin on Biomarkers after Ureteral Stones Lithotripsy
di: Mohammed Khalid Abood, et al.
Pubblicazione: (2015-12-01)

Benign prostatic hyperplasia and periodontitis
di: YANG Shisong, et al.
Pubblicazione: (2024-03-01)

Indicators of endogenous intoxication in rats with benign hyperplasia on the background of toxic effects of ethanol
di: Yu.I. Makodrai, et al.
Pubblicazione: (2022-02-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
di: V. N. Pavlov, et al.
Pubblicazione: (2018-08-01)

Tadalafil versus tamsulosin for distal ureteric stone expulsion; a prospective randomized comparative study
di: Ahmed M. Ragheb, et al.
Pubblicazione: (2024-04-01)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
di: O.O. Sherstyuk, et al.
Pubblicazione: (2022-08-01)

Diode laser surgery for benign prostate hyperplasia: a comparative analysis of the efficacy and safety of two techniques
di: S. A. Rakhimov, et al.
Pubblicazione: (2023-12-01)

A NEW APPROACH TO THE ASSESSMENT MALE SEXUALITY IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (ROSTOV QUESTIONNAIRE)
di: A. Y. Kireev
Pubblicazione: (2013-06-01)

Laser technologies in surgery for benign prostate hyperplasia
di: S. A. Rakhimov, et al.
Pubblicazione: (2024-03-01)

Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
di: Bahar Arıcan Tarım, et al.
Pubblicazione: (2023-09-01)

Treatment outcomes of benign prostate hyperplasia by thulium vapoenucleation of the prostate in aging men
di: Chun-Ming Hou, et al.
Pubblicazione: (2016-12-01)

Diversity in microbiota between Indian and Emiratis ethnicities is associated with benign prostatic hyperplasia
di: Zainab Al Shareef, et al.
Pubblicazione: (2022-01-01)

Review of the role of pyroptosis in benign prostatic hyperplasia in old males
di: CHEN Zixuan, et al.
Pubblicazione: (2023-12-01)

OPTIMIZATION OF TREATMENT AND PROGNOSTIC APPROACHES TO BENIGN PROSTATIC HYPERPLASIA COMPLICATIONS
di: S. M. Pikalov, et al.
Pubblicazione: (2020-11-01)

Response Surface Methodology (RSM) approach to formulate and optimize the bilayer combination tablet of Tamsulosin and Finasteride
di: Muneeba Akhtar, et al.
Pubblicazione: (2024-03-01)

URINARY TRACT INFECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA ADMITTED FOR PROSTATECTOMY
di: M.H. Kamran
Pubblicazione: (2021-12-01)

Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia
di: Kensuke Mitsunari, et al.
Pubblicazione: (2021-01-01)

Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
di: Liping Wang, et al.
Pubblicazione: (2021-11-01)

Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
di: Taofiq Olayinka Mohammed, et al.
Pubblicazione: (2024-12-01)

ANALYSIS OF INSULIN RESISTANCE IN VARIOUS COMPONENTS OF METABOLIC SYNDROME
di: Pankaj Maheria, et al.
Pubblicazione: (2011-12-01)

Rauwolfia vomitoria- a promising medical plant for benign prostatic hyperplasia management; yet with challenges
di: George Awuku Asare, et al.
Pubblicazione: (2025-02-01)

Comparative assessment of attitudes and expectations: Iranian patients versus urologists in the management of benign prostatic hyperplasia
di: Jalil Hosseini, et al.
Pubblicazione: (2024-10-01)

Possibilities of Therapeutic and Prophylactic Tactics in Management of Benign Prostatic Hyperplasia in Tuberculosis Patients
di: Z. R. Rashidov, et al.
Pubblicazione: (2021-08-01)

Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone
di: Arka Banerjee, et al.
Pubblicazione: (2024-07-01)

The association between quality of life and the level of vitamin D in benign prostate hyperplasia
di: Kovačević Rada R., et al.
Pubblicazione: (2023-01-01)